Search - tctmd.com

Displaying 1 - 16 of 16

Sort: Relevancy | Date

Presentation TCT 2024

First in Man (FIM) Experience of the Vivasure PerQseal® ELITE System for Large Hole Closure: The ELITE and ELITE Venous Studies

Presenter: Nicolas Van Mieghem

October 28, 2024

Presentation TCT 2024

Final Results of the PATCH Study of the Vivasure PerQseal® System for Large Hole Closure

Presenter: William Gray

October 28, 2024

Presentation TCT 2021

TCT 558: Embolization of an Aneurysm in the Internal Iliac Artery, Followed by Correction of the Abdominal Aneurysm With the 'Aptus' System

Presenter: Jorge Luis Vivar Sanchez

November 05, 2021

Presentation TCT 2019

TCT 64: Intravascular Molecular-Structural Imaging of Arterial Permeability and Vascular Injury In Vivo: Implications for Drug-Coated Balloon Efficacy

Presenter: Mazen Albaghdadi

September 25, 2019

Presentation VIVA 2018

TOBA II 12-Month Data

Presenter: William Gray

November 09, 2018

Presentation The Structural Heart Disease Summit 2018

Pharmacologic Agents to Prevent Stroke in Nonvalvular Atrial Fibrillation and PFO: Evidence and Real-world Practices

Presenter: Anthony N. DeMaria, Vivek Y. Reddy, Gregg W. Stone

June 22, 2018

Presentation The Structural Heart Disease Summit 2018

Cardioembolic Stroke: Scope, Etiologies, Guidelines, and Uncertainties

Presenter: Anthony N. DeMaria, Vivek Y. Reddy, Rajan Gadhia

June 22, 2018

Presentation VIVA 2017

Results from the ENGAGE Registry

Presenter: Marc Schermerhorn

September 21, 2017

Presentation VIVA 2017

Is Aspirin Really a Class I Medication in Peripheral Artery Disease?

Presenter: Ehrin J. Armstrong

September 19, 2017

Presentation VIVA 2017

Results from the IN.PACT SFA Randomized Trial

Presenter: Peter A. Schneider

September 15, 2017

Presentation VIVA 2017

Two-year Results from the IN.PACT Global Study

Presenter: Thomas Zeller

September 14, 2017

Presentation VIVA 2017

Paclitaxel-Eluting Stent Treatment for PAD: Insights from the Zilver PTX Post-Market Study in Japan

Presenter: Michael Dake

September 14, 2017

Presentation ESC 2017

The Viborg Vascular (VIVA) Randomised Screening Trial

Presenter: Jes Lindholt

August 29, 2017

Presentation LAA 2017

Electrical/Ablation Approaches to AFib: Competitive or Complementary With LAA Closure?

Presenter: Vivek Y. Reddy

July 21, 2017

Presentation TCT 2015

Guidelines, Recommendations, and Reimbursement for LAA Closure: A Global Survey

Presenter: David R. Holmes Jr., Vivek Y. Reddy, Saibal Kar

October 11, 2015

Presentation TCT 2013

Effects of PRT-201, a Recombinant Human Type I Pancreatic Elastase, Treatment on the Elastin Content and Compliance of Atherosclerotic Tibial Arteries Following Ex Vivo...

Presenter: Steven Burke, Emma Moss, Karen Macdonald, Marco Wong, Daniel Gottlieb, Kimberly Bland, F. Nicholas Franano

January 31, 2013

Advertisement

First in Man (FIM) Experience of the Vivasure PerQseal® ELITE System for Large Hole Closure: The ELITE and ELITE Venous Studies

Final Results of the PATCH Study of the Vivasure PerQseal® System for Large Hole Closure

TCT 558: Embolization of an Aneurysm in the Internal Iliac Artery, Followed by Correction of the Abdominal Aneurysm With the 'Aptus' System

TCT 64: Intravascular Molecular-Structural Imaging of Arterial Permeability and Vascular Injury In Vivo: Implications for Drug-Coated Balloon Efficacy

TOBA II 12-Month Data

Pharmacologic Agents to Prevent Stroke in Nonvalvular Atrial Fibrillation and PFO: Evidence and Real-world Practices

Cardioembolic Stroke: Scope, Etiologies, Guidelines, and Uncertainties

Results from the ENGAGE Registry

Is Aspirin Really a Class I Medication in Peripheral Artery Disease?

Results from the IN.PACT SFA Randomized Trial

Two-year Results from the IN.PACT Global Study

Paclitaxel-Eluting Stent Treatment for PAD: Insights from the Zilver PTX Post-Market Study in Japan

The Viborg Vascular (VIVA) Randomised Screening Trial

Electrical/Ablation Approaches to AFib: Competitive or Complementary With LAA Closure?

Guidelines, Recommendations, and Reimbursement for LAA Closure: A Global Survey

Effects of PRT-201, a Recombinant Human Type I Pancreatic Elastase, Treatment on the Elastin Content and Compliance of Atherosclerotic Tibial Arteries Following Ex Vivo...

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content